XBRYK
LIVE

Serial Number

79390822

Owner

SAMSUNG BIOEPIS CO., LTD.

Attorney

Charles T. J. Weigell

Filing Date

Jan 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

XBRYK Trademark

Serial Number: 79390822 • Registration: 7699874

XBRYK is a trademark filed by SAMSUNG BIOEPIS CO., LTD. on January 22, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SAMSUNG BIOEPIS CO., LTD. (58 trademarks)

76, Songdogyoyuk-ro, Yeonsu-gu

Entity Type: 03

Trademark Details

Filing Date

January 22, 2024

Registration Date

February 25, 2025

Published for Opposition

January 7, 2025

Goods & Services

Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; dietary supplements; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; human vaccine preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; preparations for treatment of cancer; preparations for treatment of tumour diseases; preparations for treatment of multiple myeloma; pharmaceutical preparations for the treatment of skeletal diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of solid cancer

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 19, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 3, 2025 FICS
FINAL DISPOSITION PROCESSED
Sep 3, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 22, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 6, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 6, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 26, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 25, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 25, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 14, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 13, 2024 TROA
REFUSAL PROCESSED BY IB
Jul 28, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 8, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 8, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 18, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 17, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 7, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 24, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 13, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 7, 2024 REPR